Acute Kidney Injury (AKI) Clinical Trial
Official title:
Observational Study to Evaluate the Epidemiology of Surgical-induced Acute Kidney Injury
The evaluation of an accurate occurrence rate for AKI is of great importance for health policy, quality initiatives as well as for designing clinical trials. The primary objective is to prospectively evaluate the incidence of AKI within 72 h after extended surgical procedures that require admission to an observation unit.
Acute kidney injury (AKI) is a severe clinical complication with increasing incidence and is associated with adverse short- and long-term outcomes resulting in a major health care burden worldwide. The introduction of consensus classification systems has enhanced the awareness for AKI. The evaluation of an accurate occurrence rate for AKI is of great importance for health policy, quality initiatives as well as for designing clinical trials. However, analyzing AKI from existing databases is often limited by missing data elements, especially the inclusion of the urine output criteria. Missing data and the use of different definitions before the consensus classification are the reasons for large variations in reported occurrences of surgical induced AKI. The primary objective is to prospectively evaluate the incidence of AKI within 72 h after extended surgical procedures that require admission to an observation unit (e.g., Intensive Care Unit, Intermediate Care, Post Anesthesia Care Unit) using the latest consensus definition for AKI (Kidney Disease: Improving Global Outcomes criteria) and a standardized data collection instrument and to assess the dependence of AKI on preoperative and intraoperative factors. Method: International prospective, observational, multi-center, cross-sectional cohort study Eligible patients will be identified during preoperative assessment. All eligible patients will be approached to obtain written consent. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03941483 -
Study to Evaluate the Efficacy of ASP1128 (MA-0217) in Subjects at Risk for Acute Kidney Injury (AKI) Following Coronary Artery Bypass Graft (CABG) and/or Valve Surgery
|
Phase 2 | |
| Completed |
NCT02733328 -
Assessment of Plasma and NGAL for the Early Prediction of Acute Kidney Injury After Cardiac Surgery in Adults Study
|
||
| Completed |
NCT04829916 -
A Study to Evaluate RMC-035 in Subjects Undergoing Cardiac Surgery
|
Phase 1 | |
| Completed |
NCT05068167 -
Acute Kidney Injury as a Risk Factor for Myocardial Injury After Non Cardiac Surgery
|
||
| Terminated |
NCT02620761 -
Fenoldopam to Prevent Renal Dysfunction in Indomethacin Treated Preterm Infants
|
Phase 2/Phase 3 | |
| Recruiting |
NCT05264285 -
Mitochondrial Health and Hemodynamic Instability Related to Renal Replacement Therapy in Critically Ill Patients
|
||
| Recruiting |
NCT05399537 -
Safety Evaluation of Prismocitrate 18 in Patients Receiving CRRT
|
Phase 3 |